Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Amphastar Pharmaceuticals beat estimated earnings by 8.33%, reporting an EPS of $0.39 versus an estimate of $0.36.

Revenue was up $21.80 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 7.05% increase in the share price the next day.

Here's a look at Amphastar Pharmaceuticals's past performance:

To track all earnings releases for Amphastar Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.